INPAP vs INO: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

Both stocks have similar AI ratings. Review detailed metrics below.

INPAP
INTERNATIONAL PAPER CO /NEW/
STRONG SELL
92%
Confidence
VS
INO
INOVIO PHARMACEUTICALS, INC.
STRONG SELL
92%
Confidence

INPAP vs INO Fundamental Comparison

Metric INPAP INO
Revenue $23.6B $65,343.0
Net Income $-3.5B $-84.9M
Net Margin -14.9% -130,000.0%
ROE -23.7% -352.5%
ROA -9.3% -114.3%
Current Ratio 1.28x 1.40x
Debt/Equity 0.60x 2.60x
EPS $-6.95 $-1.81

Green = Better metric | Red = Weaker metric

View Full INPAP Analysis →
View Full INO Analysis →

You Might Also Compare

INPAP vs AAPL INO vs MSFT INPAP vs GOOGL INO vs AMZN

INPAP vs INO: Frequently Asked Questions

Is INPAP or INO a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. INPAP is rated STRONG SELL (92% confidence) while INO is rated STRONG SELL (92% confidence). This is not investment advice.

How does INPAP compare to INO fundamentally?

INTERNATIONAL PAPER CO /NEW/ has ROE of -23.7% vs INOVIO PHARMACEUTICALS, INC.'s -352.5%. Net margins are -14.9% vs -130,000.0% respectively.

Which stock pays higher dividends, INPAP or INO?

INPAP has a dividend yield of N/A or no dividend while INO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in INPAP or INO for long term?

For long-term investing, consider that INPAP has STRONG SELL rating with 92% confidence, while INO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about INPAP vs INO?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For INPAP vs INO, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.